Results

Total Results: 3,755 records

Showing results for "treatment".

341. Supplemental Items for the CAHPS Health Plan Child Survey 5.0/5.1: Children With Chronic Conditions | Agency for Healthcare Research and Quality
     www.ahrq.gov/cahps/surveys-guidance/item-sets/hp/suppl-CCC-items-hp-survey5-child.html
     April 01, 2022 - treatment. … therapy for your child? … In the last 6 months, how often was it easy to get this therapy for your child? … Did anyone from your child’s health plan, doctor’s office, or clinic help you get this therapy for your … Does your child need or get special therapy such as physical, occupational, or speech therapy?

342. Final Progress Report: Topical Vancomycin for Neurosurgery Wound Prophylaxis (pdf file)
     www.ahrq.gov/sites/default/files/2024-03/connolly-report.pdf
     January 01, 2024 - Results: The topical vancomycin treatment group comprised 484 patients (973 total enrolled patients), … For all patients randomized to the treatment group, 1 g of commercially available topical vancomycin … The operating surgeon had the right to discontinue the designated treatment drug if it violated any … aureus colonization of the anterior nares and skin, and the treatment and control groups were compared … We conclude that topical vancomycin treatment is safe in the setting of neurological surgery.

343. Chronic Obstructive Pulmonary Disease Exacerbations (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/long-term-care/one-pager-COPD.pdf
     June 02, 2021 - Sputum culture should be obtained for residents with this risk factor.1,8,9 Treatment • In additional … to standard treatment modalities (e.g., bronchodilators, anti-inflammatory agents, anti- cholinergics … discouraged unless the resident has a known history of infection due to organisms resistant to standard therapy … Use of azithromycin in the treatment of acute exacerbations of COPD. … Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).

344. Final Progress Report: Racial and Ethnic Variations in Medical Interactions (pdf file)
     www.ahrq.gov/sites/default/files/2024-07/ashton-report.pdf
     January 01, 2024 - Utterances were coded into categories, including doctors’ information giving (e.g., diagnoses, treatments … participant’s perspective of illness in terms of cause, fault, meaning, efficacy of alternative treatments … fault, 3) the amount of control the patient had over the illness, 4) the degree to which alternative therapies … To expand access to opiate replacement therapy, Congress passed the Drug Addiction Treatment Act. … In an effort to expand access to opiate replacement therapy, Congress passed the Drug Addiction Treatment

345. Sickle Cell Disease Technical Specifications (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-216-section-2-tech-specs.pdf
     June 02, 2025 - department with fever during the measurement year who received parenteral broad-spectrum antibiotic treatment … A higher proportion indicates better performance as reflected by appropriate treatment. … as follows: The percentage of eligible children who received parenteral broad-spectrum antibiotic treatment … broad-spectrum antibiotic treatment Fever Body temperature ≥ 38 degrees C (100.4 degrees F). … to an ED with fever during the measurement year and received parenteral broad-spectrum antibiotic treatment

346. Influenza (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/ambulatory-care/influenza-rsv-one-pager.pdf
     September 01, 2022 - clinical suspicion for influenza, influenza testing is not necessary; patients who meet criteria for treatment … can receive empiric antiviral therapy.2,3 • If there is not a high prevalence of influenza during flu … results in about 30 minutes and have a sensitivity and specificity of more than 90 percent.2,5 Treatment … Treatment options include the following:4 o Oseltamivir for 5 days o Zanamivir for 5 days for patients … Baloxavir as a single dose for patients ≥12 years of age • Antibiotics are not indicated for the treatment

347. SNAC Submission Form. Section 2: Detailed Measure Specifications, Attachment 2: Chart Abstratcion Algorithm (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-2-attach-2.pdf
     June 02, 2025 - as first-line treatment Step 4 Exclude any records that indicate a system reason(s) for not prescribing … behavior therapy as first-line treatment Step 5 Count the number of unique records to get the … denominator Create Numerator: Patients for whom ADHD-focused evidence-based behavior therapy was … prescribed as first-line treatment. … Step 1 Using the records in the denominator, exclude any records that indicate behavior therapy was

348. Patient Experience Measures from the CAHPS Cancer Care Survey (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/measures-cancer-509.pdf
     January 01, 2005 - Survey o Drug Therapy Survey o Cancer Surgery Survey Supplemental Items • Supplemental Items for the … modality (e.g., radiation therapy) and cancer center, and are recommended for all types of reporting … These reports can include: • Scores for patient experience with each kind of treatment (drug therapy … , radiation therapy, cancer surgery) … what cancer treatment choice was best for him/her SDM8 Doctor involved patient in cancer treatment

349. The “Sometimes Antibiotics” Diagnoses: Sinusitis – Slides
     www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/ambulatory-care/sinusitis-slides.pptx
     September 01, 2022 - Treatment should be directed at relief of symptoms such as with decongestants. … Diagnosis and treatment recommendations are the same as in adults. … for bacterial sinusitis, and treatment is 5–7 days Recommendations for symptomatic therapy should be … Patient Handout: The Patient Handout explains the symptoms and symptomatic treatment of sinusitis and … Uncomplicated acute sinusitis and rhinosinusitis in adults: Treatment. UpToDate.

350. The SHARE Approach: Facilitator's Guide (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/sdm/share-approach/share-facilitator-guide.pdf
     October 01, 2024 - > Purpose: Practice communicating about risk and benefit of treatments in a way patients can understand … > There is good information about how these treatments differ that I’d like to discuss with you before … or treatment]? … > The treatments I just described are not always effective for everyone, and the chances of having … Help your patient explore and compare treatment options > I presented all of the reasonable treatment

351. Final Progress Report: ED Staffing and Patient Outcomes (pdf file)
     www.ahrq.gov/sites/default/files/2024-09/bickell-report.pdf
     January 01, 2024 - Harvard Medical Practice Study, and most of these errors were due to diagnostic mishaps, noninvasive therapeutic … mishaps, and delays in diagnosis and treatment (1). … In addition to the data collected in the “Assessing the Variability in Time to Treatment in Surgery … These staff can hasten the processes required for diagnosis and treatment. … Why do delays in treatment occur? Lessons learned from ruptured appendicitis.

352. Slide 1 (ppt file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/presentations/2008update-overview/slide.ppt
     May 07, 2008 - Its emphasis is on treatment in a health care setting. … No other mono-therapy, medicine combination or altered duration which could be tested were found to be … However, effective treatments exist that can significantly increase rates of long-term abstinence. … Tobacco dependence treatments are effective across a broad range of populations. … Providing coverage for these treatments increases quit rates.

353. Measuring Safety: A New Perspective on Outcomes of a Long-term Intensive Case Management Program (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Cotayo.pdf
     April 22, 2004 - ; complex treatment regimen, like electroconvulsive therapy (ECT), or new technologies; discharge against … medical advice from inpatient treatment; refractory to medication interventions; and need for therapy … , group, and family therapy; and chemical dependency services. … acute and residential care) and outpatient (partial hospital, intensive outpatient programs, in-home therapy … services, outpatient therapy services) care in the 12 months before and the 12 months after the ICM

354. Manténgase activo y saludable con los diluyentes de la sangre - Transcript | Agency for Healthcare Research and Quality
     www.ahrq.gov/patients-consumers/diagnosis-treatment/treatments/btpills/activeesp-tr.html
     September 01, 2017 - Manténgase activo y saludable con los diluyentes de la sangre - Transcript Reporte Especial: Medicamentos Diluyentes de la Sangre Narrador:  Recientemente su médico le recetó un medicamento que diluye la sangre tal como la warfarina y probablemente tienen muchas preguntas. Por favor relájese y siéntese cómoda…

355. Staying Active and Healthy with Blood Thinners - Transcript | Agency for Healthcare Research and Quality
     www.ahrq.gov/patients-consumers/diagnosis-treatment/treatments/btpills/stayactive-tr.html
     September 01, 2015 - By doing these things, you are sure to have success in integrating your blood thinner therapy into your

356. Preguntas que debe hacer antes de tomar el medicamento | Agency for Healthcare Research and Quality
     www.ahrq.gov/patients-consumers/diagnosis-treatment/treatments/safemedsp/preguntas-medicamento.html
     August 01, 2017 - Su medicamento: Infórmese. Evite riesgos. (Incluye tarjeta de bolsillo) Preguntas que debe hacer antes de tomar el medicamento 1. ¿Por qué tomo este medicamento? ______________________________________________________________________ _______________________________________________________________…

357. Notas | Agency for Healthcare Research and Quality
     www.ahrq.gov/patients-consumers/diagnosis-treatment/treatments/safemedsp/notas-medicamento.html
     August 01, 2017 - Su medicamento: Infórmese. Evite riesgos. (Incluye tarjeta de bolsillo) Notas ______________________________________________________________________ ______________________________________________________________________ ______________________________________________________________________ _…

358. Section 1, Table 1 to 4 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0217-section-1-tables-1-4.pdf
     June 02, 2025 - Documentation of pain assessment (including location, intensity and description) prior to initiation of treatment … Documentation of pain assessment (including location, intensity and description) prior to initiation of treatment … documentation of pain assessment (including location, intensity and description) prior to initiation of treatment … Documentation of pain assessment (including location, intensity and description) prior to initiation of treatment

359. Improving Nonsurgical Management of Urinary Incontinence in Women (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/projects/urinary/managing-urinary-incontinence-slides.pdf
     October 14, 2022 - complete evaluation 17 MUI Initiative Purpose Grants: ► Make nonsurgical treatments … fit” based on her values, treatment goals, and risk-benefit tradeoff … • Patient have more background knowledge of UI and treatment options to make shared decision-making … • Order sets to facilitate referrals to local resources, physical therapy, evidence-based medications … • All treatment is provided at no charge. • There are no in-person visits.

360. The Never Antibiotics Diagnoses: Influenza and RSV – Facilitator Guide (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/ambulatory-care/influenza-rsv-guide.docx
     September 01, 2022 - can receive empiric therapy. … Slide 16 Moment 3: Treatment SAY: Consider antiviral treatment for adults and children who are household … If initiated within 48 hours of symptom onset, antiviral therapy is expected to reduce the duration of … Slide 31 Moment 3: Treatment SAY: Antiviral therapy, such as ribavirin, should not be routinely used … Instead, treat with supportive therapy such as oral rehydration solution, acetaminophen or ibuprofen,